NewsBenzingaLa adquisición de Bolt lo posiciona para impulsar la cartera de anticuerpos multiespecíficos Inspire de Prana; se esperan resultados de la fase 2 de PRA-216 a partir del segundo trimestre de 2027 La adquisición de Bolt lo posiciona para impulsar la cartera de anticuerpos multiespecíficos Inspire de Prana; se esperan resultados de la fase 2 de PRA-216 a partir del segundo trimestre de 2027 Benzinga 2026.10.23 13:22 (GMT+0) Open on Benzinga Other news Musk: Expects SpaceX to sell no compute to OpenAI Wall Street prepares for Anthropic IPO frenzy, despite broader AI stock slump Iron Mountain Stock: Is Wall Street Bullish or Bearish? HTX DeepThink: Leverage Flush-Out May Not Mark a Bottom; Weak Spot Demand Could Keep BTC Under Pressure What Wall Street analysts are now saying after Nvidia’s beat-and-raise quarter More Than a Swap: PancakeSwap Rebrands as Pancake Ahead of Mobile App Launch
HTX DeepThink: Leverage Flush-Out May Not Mark a Bottom; Weak Spot Demand Could Keep BTC Under Pressure